Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
about
Anti-vascular endothelial growth factor for diabetic macular oedemaAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaDiabetic macular edema: it is more than just VEGFDiabetic Macular EdemaUpdates on the Clinical Trials in Diabetic Macular EdemaRole of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implantThe clinical utility of aflibercept for diabetic macular edemaAnti-VEGF Therapy and the Retina: An UpdatePerspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedemaThe role of aflibercept in the management of diabetic macular edemaNeuroinflammatory responses in diabetic retinopathyIndividualized Treatment of Neovascular Age-Related Macular Degeneration: What are Patients Gaining? Or Losing?Laser, intravitreal drug application, and surgery to treat diabetic eye diseaseDiabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomicsReceptor tyrosine kinase-mediated angiogenesisNovel pharmacotherapies in diabetic retinopathyA review of therapies for diabetic macular oedema and rationale for combination therapySpectral-domain optical coherence tomography for macular edemaTreatment of diabetic retinopathy: Recent advances and unresolved challengesDiabetic Macular Edema Pathophysiology: Vasogenic versus InflammatoryAdministration of Traditional Chinese Blood Circulation Activating Drugs for Microvascular Complications in Patients with Type 2 Diabetes MellitusMoving Past Anti-VEGF: Novel Therapies for Treating Diabetic RetinopathyCurrent perspectives on ranibizumabLong-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edemaThe Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial CellsStandards of medical care in diabetes--2013Diabetic macular oedema: evidence-based treatment recommendations for Asian countries.Vascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy.Adipose-derived stem cells from diabetic mice show impaired vascular stabilization in a murine model of diabetic retinopathy.Diabetic macular edema: New promising therapies.CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMA.Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study.Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials.Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edemaEffect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema.New Therapeutic Approaches in Diabetic Retinopathy.Predictive factors of better outcomes by monotherapy of an antivascular endothelial growth factor drug, ranibizumab, for diabetic macular edema in clinical practice.Cost-effectiveness of treatment of diabetic macular edema.Foveal thickness reduction after anti-vascular endothelial growth factor treatment in chronic diabetic macular edema.Prognostic factors of short-term outcomes of intravitreal ranibizumab in diabetic macular edema.
P2860
Q24193083-C773DE2F-D326-400E-98BE-CEF030956BD0Q24202071-DCF6189C-1D76-42C8-BFCB-7006F1EB834AQ26745914-BA31137A-E720-4A31-82D7-1EDB1359F5CDQ26749438-AB7F6BC1-AD42-4F72-A762-8A0A3BA96196Q26767100-B9A1DDA0-4C92-47E0-B8E2-FF0D0E80A960Q26775853-7C6C4408-05C1-47D7-AFA2-42E9A4B26725Q26783575-2C36DA42-A07F-45EF-B110-4E9D6A8FDF2EQ26784605-B62AA5DA-7DF9-4326-8407-F0BBF4A375B3Q26786012-2E79692F-15D5-4856-89BB-42208FCC3170Q26798348-D75684BB-196A-4F71-A905-3F9A40FF14C2Q26798351-66ABB230-89E8-458D-812E-7DE52A22BB5FQ26799492-D71062C6-6E85-4262-AF55-99417ADA583BQ26995365-644D8F4B-D75C-4843-98F7-8CADCAAD99A1Q26998543-13E75DE4-8AD0-4A35-B018-44511D03E461Q27001612-ED9523FE-FDC6-476F-B648-77D65CA5EDCDQ27002622-C75A059B-F666-4413-B3CA-6A9D5E94FAB5Q27008325-C5DEE934-B8F5-46F0-A2C4-4DF6141B8B80Q27016124-810E91BA-2ECB-45BD-AE68-C1BE81E732B2Q28067491-A376ED48-D73A-49F4-A1B7-DD2D9361648EQ28070894-E8AB54F1-75B6-479F-8732-BB0AC302EC15Q28072087-861030A2-9BF7-49FE-8920-2C013C90F648Q28078199-47B140C9-BCB5-42C7-915C-DC934D81DA0AQ28082383-00FCBF93-1507-4BF6-A14F-FDA49FBA7C16Q28292764-CD735050-88F3-4D6E-A1F1-494F5D6AA507Q28550616-3D158237-5756-4E8F-A72A-1C55EC7CB936Q29620309-A0BF9C63-8C4E-4953-B455-CDDE7318E795Q30101045-B141424C-BF29-4FFE-88F8-14435E0B1DABQ30244247-26CDE0DB-B0EF-402E-B7C9-8607FDA293B8Q30300372-1420A500-7C26-45B3-A595-602ABE759622Q30415630-C76BDC8D-2E75-48E1-9B7F-1CE1210D6DD9Q30491050-086E3FD0-4404-49BB-BB36-38A6E2F83E61Q31131691-64BD9606-DA1A-4C8F-AFD7-0E928B8559E1Q31155420-E2EA8CA1-328C-4C62-A1CF-BC4F4A8D2243Q33563100-AD3F42CB-CE3A-47FF-8AED-C355B396D043Q33568545-24CE1353-DE14-4838-AD3C-0CA89DFC0A63Q33583037-9ADE3E1A-78C5-40E9-B2F0-CAFEAE267370Q33606076-00392AC3-0C64-48A3-B4D1-E5EE92167A4FQ33606611-ED78903C-AAE9-498F-A4A6-BE1622C62DECQ33706093-249456B9-E997-48CA-B811-DA7B773BCA44Q33706098-8E44B273-7C06-4A2C-B2F5-B255AA2E8692
P2860
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Ranibizumab for diabetic macul ...... domized trials: RISE and RIDE.
@ast
Ranibizumab for diabetic macul ...... domized trials: RISE and RIDE.
@en
Ranibizumab for diabetic macul ...... domized trials: RISE and RIDE.
@nl
type
label
Ranibizumab for diabetic macul ...... domized trials: RISE and RIDE.
@ast
Ranibizumab for diabetic macul ...... domized trials: RISE and RIDE.
@en
Ranibizumab for diabetic macul ...... domized trials: RISE and RIDE.
@nl
prefLabel
Ranibizumab for diabetic macul ...... domized trials: RISE and RIDE.
@ast
Ranibizumab for diabetic macul ...... domized trials: RISE and RIDE.
@en
Ranibizumab for diabetic macul ...... domized trials: RISE and RIDE.
@nl
P2093
P1433
P1476
Ranibizumab for diabetic macul ...... domized trials: RISE and RIDE.
@en
P2093
Amy Chen Rundle
Andrea Gibson
David M Brown
David S Boyer
Dennis M Marcus
J Jill Hopkins
Jason S Ehrlich
Leonard Feiner
Quan Dong Nguyen
P304
P356
10.1016/J.OPHTHA.2011.12.039
P577
2012-02-11T00:00:00Z